연구성과로 돌아가기

2024 연구성과별 연구자 정보 (1329 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis Park, Sohee Park, S 5 Aston Univ, Sch Pharm, Birmingham, England 0000-0001-7829-4131 Park, Sohee shin.jy@skku.edu;20050078@kuh.ac.kr;
Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis Noh, Yunha Noh, Y 6 Sungkyunkwan Univ, Sch Pharm, 2066 Saburo, Suwon 16419, Gyeonggi Do, South Korea GRR-1878-2022 noh, yunha 0000-0002-3645-7358 Noh, Yunha shin.jy@skku.edu;20050078@kuh.ac.kr;
Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis Noh, Yunha Noh, Y 6 McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada GRR-1878-2022 noh, yunha 0000-0002-3645-7358 Noh, Yunha shin.jy@skku.edu;20050078@kuh.ac.kr;
Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis Jeon, Ja-Young Jeon, JY 7 Pfizer Pharmaceut Korea Ltd, Dept Inflammat & Immunol Med Affairs, Seoul, South Korea shin.jy@skku.edu;20050078@kuh.ac.kr;
Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis Yoo, Eun-Young Yoo, EY 8 Pfizer Pharmaceut Korea Ltd, Dept Inflammat & Immunol Med Affairs, Seoul, South Korea shin.jy@skku.edu;20050078@kuh.ac.kr;
Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis Shin, Ju-Young Shin, JY 9 교신저자 Sungkyunkwan Univ, Sch Pharm, 2066 Saburo, Suwon 16419, Gyeonggi Do, South Korea shin.jy@skku.edu;20050078@kuh.ac.kr;
Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis Shin, Ju-Young Shin, JY 9 교신저자 Sungkyunkwan Univ, Dept Biohlth Regulatory Sci, Suwon, South Korea shin.jy@skku.edu;20050078@kuh.ac.kr;
Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis Shin, Ju-Young Shin, JY 9 교신저자 Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea shin.jy@skku.edu;20050078@kuh.ac.kr;
Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis Lee, Yang Won Lee, YW 10 교신저자 Konkuk Univ, Sch Med, Dept Dermatol, 120-1 Neungdong Ro, Seoul 05030, South Korea shin.jy@skku.edu;20050078@kuh.ac.kr;
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment Duong Duc Pham Pham, DD 1 Univ Ulsan, Coll Med, Dept Allergy & Clin Immunol, Asan Med Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea D-4674-2013 Pham, Duong tbkim@amc.seoul.kr;
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment Lee, Ji-Hyang Lee, JH 2 Univ Ulsan, Coll Med, Dept Allergy & Clin Immunol, Asan Med Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea tbkim@amc.seoul.kr;
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment Kwon, Hyouk-Soo Kwon, HS 3 Univ Ulsan, Coll Med, Dept Allergy & Clin Immunol, Asan Med Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea tbkim@amc.seoul.kr;
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment Song, Woo-Jung Song, WJ 4 Univ Ulsan, Coll Med, Dept Allergy & Clin Immunol, Asan Med Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea tbkim@amc.seoul.kr;
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment Cho, You Sook Cho, YS 5 Univ Ulsan, Coll Med, Dept Allergy & Clin Immunol, Asan Med Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea tbkim@amc.seoul.kr;
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment Kim, Hyunkyoung Kim, H 6 Univ Ulsan, Coll Med, Dept Allergy & Clin Immunol, Asan Med Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea tbkim@amc.seoul.kr;
페이지 이동: